BK virus nephropathy: a pediatric nephrologist's perspective

Transplantation Reviews

Volumn 24, Issue 1, 2010, Pages 28-31

  Hymes, Leonard ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CALCINEURIN INHIBITOR; CIDOFOVIR; LEFLUNOMIDE; MYCOPHENOLIC ACID; RAPAMYCIN;

ARTICLE; BK VIRUS; CLINICAL TRIAL; DOSE RESPONSE; DRUG DOSE COMPARISON; DRUG EFFICACY; GRAFT FAILURE; GRAFT RECIPIENT; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INCIDENCE; INFECTION RISK; KIDNEY GRAFT REJECTION; KIDNEY INFECTION; KIDNEY TRANSPLANTATION; PEDIATRIC SURGERY; RENAL GRAFT DYSFUNCTION; RISK FACTOR; THERAPY EFFECT; TREATMENT OUTCOME;

EID: 70449720540     PISSN: 0955470X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.trre.2009.09.002     Document Type: Article

References (27)

1. Ramos E., Drachenberg C.B., Wali R., et al. The decade of polyomavirus BK-associated nephropathy: state of affairs. Transplantation 87 (2009) 621-630
2. Harihana S. BK virus nephritis after renal transplantation. Kidney Int 69 (2006) 655-662
3. Rajpoor D.K., Gomez A., Tsang W., et al. Ureteral and urethral stenosis: a complication BK virus infection in a pediatric transplant patient. Pediatr Transplant 17 (2007) 605-606
4. Emerson L.L., Carney H.M., Layfield L.J., et al. Collecting duct carcinoma arising in association with BK nephropathy post-transplantation in a pediatric patient. A case report with immunohistochemical and in situ hybridization study. Pediatr Transplant 12 (2008) 600-6006
5. Alcott P.D., and Hirsch H.H. BK virus infection, replication, and diseases in pediatric transplantation. Pediatr Nephrol 22 (2007) 1243-1250
6. Weiss A.S., Grall J., Chan L., et al. Aggressive immunosuppression minimization reduces graft loss following diagnosis of BK virus-associated nephropathy: a comparison of two reduction strategies. Clin J Am Soc Nephrol 3 (2008) 1812-1819
7. Smith J., Dharnidharka V., Talley L., et al. BK virus nephropathy in pediatric renal transplant patients: an analysis of the North American Pediatric Renal Trials and Collaborative Studies (NAPRTCS) Registry. Clin J Am Soc Nephrol 2 (2007) 1037-1042
8. Ginevri F., De Santis R., Comoli P., et al. Polyomavirus BK infection in pediatric kidney-allograft recipients: a single center analysis of incidence, risk factors and novel therapeutic approaches. Transplantation 75 (2003) 1266-1270
9. Hayson L., Rosenberg A.R., Kainer G., et al. BK viral infection in a Australian pediatric renal transplant population. Pediatr Tansplant 8 (2004) 480-484
10. Muller A., Beck B., Theilemann K., et al. Detection of polyomavirus BK and JC in children with kidney diseases and renal transplant recipients. Pediatr Infect Dis J 24 (2005) 778-791
11. Hymes L.C., and Warshaw B.L. Polyomavirus (BK) in pediatric renal transplants: evaluation of viremic patients with and without BK associated nephritis. Pediatr Transpl 10 (2006) 920-922
12. Binet I., Nickeleit V., Hirsch H.H., et al. Polyoma disease under new immunosuppression drugs: a cause of renal graft dysfunction and graft loss. Transplantation 67 (1999) 918-922
13. Rhanhawa P.S., Finkelstein S., Scantlebury V., et al. Human polyoma virus-associated interstitial nephritis in the allograft kidney. Transplantation 67 (1999) 103-109
14. Herman J., Van Ranst M., Snoek R., et al. Polyomavirus infection in pediatric renal transplant recipients: Evaluation using quantitative real-time PCR technique. Pediatr Transplant 8 (2004) 485-492
15. Alexander R.T., Langlois V., Tellier R., et al. The prevalence of BK viremia and urinary shedding in a pediatric renal transplant population: a single-center retrospective analysis. Pediatr Transplant 10 (2006) 586-592
16. Puliyanda D.P., Toyoda M., Traum A.Z., et al. Outcome of management strategies for BK virus replication in pediatric renal transplant recipients. Pediatr Transplant 12 (2008) 180-186
17. Vats A., Shapiro R., Singh P., et al. Quantitative viral load monitoring and cidofovir therapy in children and adults. Transplantation 75 (2003) 105-112
18. Ayala C.E., Lew J.F., Fennell R.S., et al. Intermediate-dose cidofovir without probenicid in the treatment of BK virus allograft nephropathy. Pediatr Transplant 10 (2006) 32-37
19. Araya C.E., Lew J.F., Fennell R.S., et al. Intermediate dose cidofovir does not cause additive nephrotoxicity in BK virus allograft nephropathy. Pediatr Transplant 12 (2008) 790-795
20. Wu J.K., and Harris M.T. Use of leflunomide in the treatment of polyomavirus BK-associated nephropathy. Ann Pharmocother 42 (2008) 1679-1685
21. Leca N., Muczynski K.A., Jefferson J.A., et al. Higher levels of leflunomide are associated with hemolysis and are not superior to lower levels for BK virus clearance in renal transplant patients. Clin J Am Soc Nephrol 3 (2008) 829-835
22. Hymes L.C., Warshaw B.L., Amaral S.G., et al. Polyoma (BK) virus nephropathy: response to treatment with cidofovir and leflunomide in pediatric renal transplants. American Society of Nephrology, San Diego, CA, October 27-November 1 (2009) [abstract]
23. Hymes L., Greenbaum L., Amaral S., et al. Surveillance renal transplant biopsies and subclinical rejection at three months post-transplant in pediatric recipients. Pediatr Transplant 11 (2007) 536-539
24. Hirsch H.H., Knowles W., Dickenmann M., et al. Prospective study of polyomavirus type BK replication and nephropathy in renal transplant recipients. N Engl J Med 347 (2002) 488-496
25. Bijol V, Cimini A, Viscidi RJ, et al. Pre-transplant IgG antibodies to polyoma BK virus in pediatric renal transplants. Pediatr Transplant (in press).
26. Smith J.M., McDonald R.A., Finn L.S., et al. Polyomavirus nephropathy in pediatric transplant recipients. Am J Transplant 4 (2004) 2109-2117
27. Hariharan S., Cohen E.P., Vasudev B., et al. BK virus-specific antibodies and BKV DNA in renal transplant recipients with BKV nephritis. Am J Transplant 5 (2005) 2719-2724